PET imaging study for multiple solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of one of the following cancers: malignant melanoma, glioma, lung, colon, pancreatic, gastric, breast, or liver cancer
- You are between 18 and 75 years old
- You are able to carry out your daily activities without help (ECOG 0 or 1)
- Your doctor expects you to live at least 6 months
- You have at least one tumor that can be measured on a scan and can have a biopsy (tissue sample) taken
- You agree to use effective birth control if you are able to have children
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This trial tests a special imaging agent (a nanobody probe) that targets a protein called CD147 on tumor cells. If you have a solid tumor like melanoma, liver, colorectal, pancreatic, breast, stomach, or lung cancer, the PET scan may help doctors see your cancer more clearly.
This study uses a special PET scan to see if a new imaging agent can help find and monitor certain solid tumors. It is for people with colon, rectal, sarcoma, breast, lung, head and neck, esophageal, stomach, pancreas, bladder cancers, or glioblastoma who have had standard treatment before surgery.
This trial tests how well a special PET/CT scan with a radioactive tracer called F18 FBPA can detect different types of solid tumors. It aims to see if this scan is safe and effective at finding tumors.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This trial uses a new radioactive tracer that attaches to a protein found on many solid tumors, allowing doctors to see tumors on a PET scan. It may help improve how tumors are detected and monitored.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.